Background and episodic breathlessness in advanced cancer patients followed at home

References

• Parshall MB, Schwartzstein RM, Adams L, et al.; American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185:435-52
   PubMed Web of Science ®Google Scholar
• Currow DC, Higginson IJ, Johnson MJ. Breathlessness. Current and emerging mechanisms, measurement and management. A discussion from an European Association of Palliative Care workshop. Palliat Med 2013;27:932-8
   PubMed Web of Science ®Google Scholar
• Vainio A, Auvinen A. prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage 1996;12:3-10
   PubMed Web of Science ®Google Scholar
• Dudgeon DJ, Kristjanson L, Sloan JA, et al. Dyspnea in cancer patients: prevalence and associated factors. J Pain Symptom Manage 2001;21:92-5
   PubMed Web of Science ®Google Scholar
• Barbera L, Seow H, Howell D, et al. Symptom burden and performance status in a population-based cohort of ambulatory cancer patients. Cancer 2010;116:5767-76
   PubMed Web of Science ®Google Scholar
• Mercadante S, Marchetti P, Cuomo A, et al.; IOPS MS study Group. Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group. Support Care Cancer 2016;24:961-8
   PubMed Web of Science ®Google Scholar
• Mercadante S, Casuccio A, Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage 2000;20:104-12
   PubMed Web of Science ®Google Scholar
• Mercadante S, Porzio G, Valle A, et al. Emergencies in patients with advanced cancer followed at home. J Pain Symptom Manage 2012;44:295-300
   PubMed Web of Science ®Google Scholar
• Escalante CP, Martin CG, Elting LS, et al. Identifying risk factors for imminent death in cancer patients with acute dyspnea. J Pain Symptom Manage 2000;20:318-25
   PubMed Web of Science ®Google Scholar
• Mercadante S, Masedu F, Valenti M, et al. The characteristics of advanced cancer patients followed at home, but admitted to the hospital for the last days of life. Intern Emerg Med 2016;11:713-8
   PubMed Web of Science ®Google Scholar
• Mercadante S, Valle A, Porzio G, et al.; Home Care – Italy (HOCAI) Group. How do cancer patients receiving palliative care at home die? A descriptive study. J Pain Symptom Manage 2011;42:702-9
   PubMed Web of Science ®Google Scholar
• Mercadante S, Porzio G, Valle A, et al. Palliative sedation in patients with advanced cancer followed at home: a prospective study. J Pain Symptom Manage 2014;47:860-6
   PubMed Web of Science ®Google Scholar
• Mercadante S, Aielli F, Adile C, et al. Epidemiology and characteristics of episodic breathlessness in advanced cancer patients: an observational study. J Pain Symptom Manage 2016;51:17-24
   PubMed Web of Science ®Google Scholar
• Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996;32A:1135-41
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Bland JM, Oxberry S, et al. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage 2013;46:957-63
   PubMed Web of Science ®Google Scholar
• Bruera E, Schmitz B, Pither J, et al. The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000;19:357-62
   PubMed Web of Science ®Google Scholar
• Tanaka K, Akechi T, Okuyama T, et al. Factors correlated with dyspnea in advanced lung cancer patients: organic causes and what else? J Pain Symptom Manage 2002;23:490-500
   PubMed Web of Science ®Google Scholar
• Tanaka K, Akechi T, Okuyama T, et al. Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 2002;23:484-9
   PubMed Web of Science ®Google Scholar
• Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277-84
   PubMed Web of Science ®Google Scholar
• O’Driscoll M, Corner J, Bailey C. The experience of breathlessness in lung cancer patients. Eur J Cancer Care 1999;8:37-43
   PubMed Web of Science ®Google Scholar
• Currow DC, Quinn S, Greene A, et al. The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea. J Palliat Med 2013;16:851-86
   Web of Science ®Google Scholar
• Mercadante S, Adile C, Torta R, et al. Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients. Curr Med Res Opin 2013;29:93-7
   PubMed Web of Science ®Google Scholar
• Simon ST, Weingartner V, Higginson IJ, et al. Definition, categorization, and terminology of episodic breathlessness: consensus by an international Delphi survey. J Pain Symptom Manage 2014;47:828-38
   PubMed Web of Science ®Google Scholar
• Reddy SK, Parsons HA, Elsayem A, et al. Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 2009;12:29-36
   PubMed Web of Science ®Google Scholar
• Simon ST, Weingärtner V, Higginson IJ, et al. “I can breath again” patients’ self-management strategies for episodic breathlessness in advanced disease, derived from qualitative interviews. J Pain Symptom Manage 2016;52:228-34
   PubMed Web of Science ®Google Scholar
• Simon ST, Bausewein C, Schildmann E, et al. Episodic breathlessness in patients with advanced disease: a systematic review. J Pain Symptom Manage 2013,45:561-78
   PubMed Web of Science ®Google Scholar
• Simon ST, Higginson IJ, Benalia HH, et al. Episodic and continuous breathlessness: a new categorization of breathlessness. J Pain Symptom Manage 2013;45:1019-29
   PubMed Web of Science ®Google Scholar
• Weingartner V, Scheve C, Gerdes V, et al. Characteristics of episodic breathlessness as reported by patients with advanced chronic obstructive pulmonary disease and lung cancer: results of a descriptive color study. Palliat Med 2015;29:420-8
   PubMed Web of Science ®Google Scholar
• Davies A, Buchanan A, Zeppetella G, et al. Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manage 2013;46:619-28
   PubMed Web of Science ®Google Scholar
• Hui D, Xu A, Frisbee-Hume S, et al. Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial. J Pain Symptom Manage 2014;47:209-27
   PubMed Web of Science ®Google Scholar
• Mercadante S, Vitrano V. Palliative care in Italy: problem areas emerging from the literature. Minerva Anestesiol 2010;76:1060-71
   PubMed Web of Science ®Google Scholar
• Mercadante S. Pharmacotherapy for breakthrough cancer pain. Drugs 2012;72:181-90
   PubMed Web of Science ®Google Scholar
• Hui D, Kilgore K, Park M, et al. Impact of prophylactic fentanyl pectin nasal spray on exercise-induced episodic dyspnea in cancer patients. A double-blind randomized controlled trial. J Pain Symptom Manage 2016;52:459-468
   PubMed Web of Science ®Google Scholar
• Simon ST, Koskeroglu P, Gaertner J, Voltz R. fentanyl for the relief of refractory breathlessness: a systematic review. J Pain Symptom Manage 2013;46:874-86
   PubMed Web of Science ®Google Scholar
• Løhre ET, Klepstad P, Bennett MI, et al. From “breakthrough” to “episodic” cancer pain? A European Association for Palliative Care research network expert Delphi survey toward a common terminology and classification of transient cancer pain exacerbations. J Pain Symptom Manage 2016;51:1013-19
   PubMed Web of Science ®Google Scholar